Conference Coverage
Conference Coverage
VENUS: Ustekinumab appears superior to vedolizumab for refractory Crohn’s disease
“This study adds to the literature, aiming to position these newer biologics in the treatment algorithm,” Dr. Farrah Monzur said.
Conference Coverage
Prebiotic in development shows promise for reducing GERD symptoms
A prebiotic therapy in development significantly reduced the number of days per month that people with gastroesophageal reflux disease experienced...
Conference Coverage
‘Smart toilet’ with AI automatically scans stool for blood and consistency
"There is such a need for removing the uncertainty of the patient recall about bowel movement frequency and appearance," said Dr. Sonia Grego.
Conference Coverage
Semaglutide boosts weight loss following endoscopic gastroplasty
Five patients in the combination group reverted to a nondiabetic state and were able to discontinue antidiabetic medications altogether.
Conference Coverage
Sporebiotics improve functional dyspepsia symptoms
“Studies like this may help us gain some insight into the cause of the problem,” commented Dr. Pankaj Jay Pasricha.
Conference Coverage
Some nasogastric intubation procedures lead to less aerosolization than feared
The results are important, one commenter said, but may not generalize to all procedures because of different equipment and protocols.
Conference Coverage
GI symptoms and chronic fatigue may persist months after COVID-19
Loose stools, somatization, and chronic fatigue risks increased at a mean of 5 months after SARS-CoV-2 infection, suggesting a common...
Conference Coverage
High eradication, fewer adverse events with hybrid therapy for H. pylori
High-dose dual therapy had the lowest frequency of adverse events, but significantly lower eradication rates versus hybrid or quadruple therapies...
Conference Coverage
Head-to-head trial compares ustekinumab with adalimumab in Crohn’s
“With newer drugs, there’s a critical need for head-to-head studies for us to understand where to position a lot of these agents,”said Dr. Jordan...
Conference Coverage
Microbiome therapeutic offers durable protection against C. difficile recurrence
“The hope would be that one or more ... would probably replace the vast majority of FMT [procedures] that we do clinically,”said Dr. Sahil Khanna...